Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Gliosarcoma 131Glioblastoma 128Central Nervous System Neoplasms 58Glioma 51Brain Neoplasms 48Astrocytoma 45Oligodendroglioma 32Sarcoma 23Sarcoma, Ewing 22Rhabdomyosarcoma 18Neuroblastoma 14Medulloblastoma 14Ependymoma 14Osteosarcoma 10Neoplasms 6Choroid Plexus Neoplasms 6Wilms Tumor 5Recurrence 5Ovarian Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 5Glioma, Subependymal 5Familial ependymoma 5Rhabdoid Tumor 4Pinealoma 4Optic Nerve Glioma 4Neuroectodermal Tumors, Primitive 4Leiomyosarcoma 4Diffuse Intrinsic Pontine Glioma 4Testicular Neoplasms 3Kidney Neoplasms 3

Interventions

Doxorubicin 19Ifosfamide 12Radiotherapy 11pembrolizumab 6Nivolumab 6Ipilimumab 6pazopanib 4Specimen Handling 4Radiation 4Gemcitabine 4Docetaxel 4CTLA-4 Antigen 4Biopsy 4Trabectedin 3Sunitinib 3Magnetic Resonance Spectroscopy 3pegfilgrastim 2liposomal doxorubicin 2cabozantinib 2brostallicin 2X-Rays 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Methotrexate 2Imatinib Mesylate 2Filgrastim 2Etoposide 2Diathermy 2Cisplatin 2Chemotherapy, Adjuvant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Temozolomide × Sarcoma × Clear all
NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡